Quality & complianceOfficial

Class II drug recall: Dopamine HCl Inj. (Pfizer)

🇺🇸 FDA enforcement report · Wed 23 Sep 2026

Lack of Assurance of Sterility Recall D-0853-2026; status Ongoing; distribution: US Nationwide..

Official source: FDA enforcement report ↗

Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.

More Quality & compliance All →